Sungkyunkwan University
Also known as: Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine | Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center | Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine | department of medicine, Samsung Medical Center | Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine | Department of Neurology, Samsung Medical Center | Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine | Department of Pediatrics, Samsung Medical Center | Department of Psychiatry, Samsung Medical Center | Department of Pyschiatry, Sansung Medical Center | Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine | Dept. of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine | Division of Hematology and Oncology/Samsung Medical Center | Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, | Division of Nephrology, Samsung Medical Center | Division of Oncology, Department of Medicine, Samsung Medical Center | Kanbuk Samsung Diabetes Center | Kangbuk Samsung Hospital of Korea | Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine | Kang-Buk Samsung Medical Center | Kangnam ST.Mary's Hospital | Kangpook Samsung Hospital, Samsung Medical Center | Masan Samsung Hospital, South Korea | Professor, Department of Emergency Medicine, Samsung Medical Center | Professor(Samsung Medical Center) | Samsung Biomedical Research Institute | Samsung Changwon Hospital | Samsung Genomic Institute | SamsungMedicalCenter | Samsung Medical Center | Samsung Medical Center, 50 Irwon-Dong, Gangnam-Gu, Special city of Seoul, 135-710, Korea | Samsung Medical Center, Department of Internal Medicine | Samsung Medical Center, Department of Neurology | Samsung Medical Center, Department of Otorhinolaryngoloty | Samsung Medical Center of Korea | Samsung Medical Center, Professor of department of clinical pharmacology | Samsung Medical Center Seoul | Samsung Medical Center -Seoul | Samsung Medical Center, Seoul | Samsung Medical Center, Seoul, Korea | Samsung Medical Center,Seoul,Korea | Samsung Medical Center, Seoul, KOREA | Samsung medical center, Seoul, Republic of Korea | Samsung Medical Center (SMC) | Samsung Medical Center(SMC) | Samsung Medical Center, South Korea | Samsung Medical Center, Sungkyunkwan University School of Medicine | Samsung Medical Centre | Samsung Medical Centre Sungkyunkwan University School of Medicine | Samsung Medical Conter | Samsung Meical Center | Samsung seoul hospital | Samsung Seoul Hospital | Samsung Seoul Hospital, Samsung Medical Center | Sanmsung Medical Center | Seoul Samsung Medical center. | Sumsung Medical Center | Sungkyunkwan University | Sungkyunkwan University Kangbuk Samsung Hospital | Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea | Sungkyunkwan University School of Medicine, 135-710, Seoul, Korea | Sungkyunkwan University School of Medicine, Samsung Medical Center, Gangnam-gu, Seoul, Korea | Tae Gun Shin | Won Seog Kim
Highest phase reached
Phase 4
First clinical trial
May 1, 1998Last known activity
Jan 31, 2026
Timeline
1390s
- Jan 1, 1398
Sungkyunkwan University— Founded
Drugs by trial phase (459 distinct, 623 trials)
Phase 4 (116 own, 0 via acquisition)
Phase 3 (103 own, 0 via acquisition)
Phase 2 (154 own, 0 via acquisition)
Phase 1 (39 own, 0 via acquisition)
Other trials (47 own, 0 via acquisition)
Indications
Studied for
- Acromegaly
- Acute Radiation Syndrome
- Adenocarcinoma
- Adenocarcinoma of Lung
- Adenoma
- Albuminuria
- Alzheimer Disease
- Anemia
- Angina Pectoris
- Angina Pectoris, Variant
- Anovulation
- Aortic Valve Stenosis
- Arachnodactyly
- Arthritis
- Ascites
- Atherosclerosis
- Atrial Fibrillation
- Autistic Disorder
- Behcet Syndrome
- Biliary Tract Neoplasms
- Blepharospasm
- Blood Coagulation Disorders
- Brain Neoplasms
- Breast Diseases
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Calculi
- Cancer Pain
- Carcinoma
- Carcinoma, Ductal
- Carcinoma, Hepatocellular
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carotid Stenosis
- Cataract
- Cerebral Palsy
- Chest Pain
- Cholangiocarcinoma
- Cholangitis
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Consciousness Disorders
- Constriction, Pathologic
- Coronary Artery Disease
- Coronary Disease
- Crohn Disease
- Cytomegalovirus Infections
- Dementia
- Dementia, Vascular
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Digestive System Neoplasms
- Disease
- Disease Progression
- Disruptive, Impulse Control, and Conduct Disorders
- Dry Eye Syndromes
- Ductus Arteriosus, Patent
- Dwarfism
- Dyslipidemias
- Dyspepsia
- Dyssomnias
- Edema
- Encephalitis
- Encephalitis, Japanese
- Erectile Dysfunction
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Esophagitis
- Esophagitis, Peptic
- Essential Hypertension
- Familial Primary Pulmonary Hypertension
- Femoral Neck Fractures
- Femur Head Necrosis
- Fistula
- Gallbladder Neoplasms
- Gastritis
- Gastroesophageal Reflux
- Gastrointestinal Neoplasms
- Gastrointestinal Stromal Tumors
- Germinoma
- Glaucoma
- Glioblastoma
- Graft vs Host Disease
- Growth Hormone-Secreting Pituitary Adenoma
- Head and Neck Neoplasms
- Heart Arrest
- Helicobacter Infections
- Hemorrhage
- Hemostatic Disorders
- Hepatitis
- Hepatitis A
Recent trials (50)
- NCT07300891Lead sponsorPhase 2Jan 31, 2026
- NCT07300891Sponsor investigatorPhase 2Jan 31, 2026
- NCT07115173Lead sponsorPhase 4Dec 1, 2025
- NCT07240844CollaboratorPhase 4Nov 24, 2025
- NCT07028008Lead sponsorN/AOct 15, 2025
- NCT07028008Sponsor investigatorN/AOct 15, 2025
- NCT07121478CollaboratorPhase 2Sep 23, 2025
- NCT07225374Sponsor investigatorPhase 2Sep 16, 2025
- NCT07225374Lead sponsorPhase 2Sep 16, 2025
- NCT07225374OfficialPhase 2Sep 16, 2025
- NCT06893783CollaboratorPhase 2Sep 2, 2025
- NCT06942156OfficialPhase 4Aug 14, 2025
- NCT06849947Lead sponsorPhase 2Jun 30, 2025
- NCT06849947Sponsor investigatorPhase 2Jun 30, 2025
- NCT06763744Lead sponsorPhase 4Jun 1, 2025
Details
- Founded
- Seoul, KR Jan 1, 1398
- Last known activity
- Jan 31, 2026